1LIFE HEALTHCARE INC (ONEM) Fundamental Analysis & Valuation
NASDAQ:ONEM • US68269G1076
Current stock price
16.47 USD
+0.46 (+2.87%)
At close:
17.87 USD
+1.4 (+8.5%)
Pre-Market:
This ONEM fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
1. ONEM Profitability Analysis
1.1 Basic Checks
- ONEM had negative earnings in the past year.
- ONEM had a negative operating cash flow in the past year.
1.2 Ratios
- ONEM has negative profitability rations, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | N/A | ||
| ROE | N/A | ||
| ROIC | N/A |
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- The Gross Margin of ONEM (17.36%) is worse than 66.96% of its industry peers.
- In the last couple of years the Gross Margin of ONEM has declined.
- The Profit Margin and Operating Margin are not available for ONEM so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 17.36% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-5.88%
GM growth 5YN/A
2. ONEM Health Analysis
2.1 Basic Checks
- ONEM does not have a ROIC to compare to the WACC, probably because it is not profitable.
- Compared to 1 year ago, ONEM has more shares outstanding
- The debt/assets ratio for ONEM has been reduced compared to a year ago.
2.2 Solvency
- Based on the Altman-Z score of 1.62, we must say that ONEM is in the distress zone and has some risk of bankruptcy.
- ONEM has a Altman-Z score of 1.62. This is comparable to the rest of the industry: ONEM outperforms 49.57% of its industry peers.
- ONEM has a Debt/Equity ratio of 0.20. This is a healthy value indicating a solid balance between debt and equity.
- ONEM has a better Debt to Equity ratio (0.20) than 74.78% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.2 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 1.62 |
ROIC/WACCN/A
WACC8.55%
2.3 Liquidity
- ONEM has a Current Ratio of 2.09. This indicates that ONEM is financially healthy and has no problem in meeting its short term obligations.
- With a decent Current ratio value of 2.09, ONEM is doing good in the industry, outperforming 78.26% of the companies in the same industry.
- ONEM has a Quick Ratio of 2.06. This indicates that ONEM is financially healthy and has no problem in meeting its short term obligations.
- Looking at the Quick ratio, with a value of 2.06, ONEM is in the better half of the industry, outperforming 79.13% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.09 | ||
| Quick Ratio | 2.06 |
3. ONEM Growth Analysis
3.1 Past
- The earnings per share for ONEM have decreased strongly by -74.14% in the last year.
- The Revenue has grown by 95.17% in the past year. This is a very strong growth!
- ONEM shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 42.97% yearly.
EPS 1Y (TTM)-74.14%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-11.76%
Revenue 1Y (TTM)95.17%
Revenue growth 3Y42.97%
Revenue growth 5YN/A
Sales Q2Q%72.71%
3.2 Future
- The Earnings Per Share is expected to decrease by -0.45% on average over the next years.
- Based on estimates for the next years, ONEM will show a very strong growth in Revenue. The Revenue will grow by 31.98% on average per year.
EPS Next Y-30.59%
EPS Next 2Y-9.15%
EPS Next 3Y-0.45%
EPS Next 5YN/A
Revenue Next Year70.69%
Revenue Next 2Y46.99%
Revenue Next 3Y38.98%
Revenue Next 5Y31.98%
3.3 Evolution
- Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
4. ONEM Valuation Analysis
4.1 Price/Earnings Ratio
- ONEM reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
- Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for ONEM. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-9.15%
EPS Next 3Y-0.45%
5. ONEM Dividend Analysis
5.1 Amount
- No dividends for ONEM!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
ONEM Fundamentals: All Metrics, Ratios and Statistics
16.47
+0.46 (+2.87%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Industry Strength45.96
Industry Growth88.2
Earnings (Last)02-22 2023-02-22
Earnings (Next)05-02 2023-05-02
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners7.7%
Ins Owner Change0%
Market Cap3.37B
Revenue(TTM)1.00B
Net Income(TTM)-392.14M
Analysts68
Price Target18.55 (12.63%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-9.71%
Min EPS beat(2)-21.97%
Max EPS beat(2)2.56%
EPS beat(4)3
Avg EPS beat(4)-1.52%
Min EPS beat(4)-21.97%
Max EPS beat(4)6.81%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-5.61%
Min Revenue beat(2)-6.08%
Max Revenue beat(2)-5.13%
Revenue beat(4)2
Avg Revenue beat(4)-1.75%
Min Revenue beat(4)-6.08%
Max Revenue beat(4)3.17%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)1.01%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)-8.04%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.34%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-2.29%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 3.36 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 2.16 | ||
| P/tB | 44.32 | ||
| EV/EBITDA | N/A |
EPS(TTM)-2.02
EYN/A
EPS(NY)-1.91
Fwd EYN/A
FCF(TTM)-1.6
FCFYN/A
OCF(TTM)-1.24
OCFYN/A
SpS4.9
BVpS7.62
TBVpS0.37
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | N/A | ||
| ROE | N/A | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 17.36% | ||
| FCFM | N/A |
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-5.88%
GM growth 5YN/A
F-Score2
Asset Turnover0.4
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.2 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | 86.11% | ||
| Cap/Sales | N/A | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 2.09 | ||
| Quick Ratio | 2.06 | ||
| Altman-Z | 1.62 |
F-Score2
WACC8.55%
ROIC/WACCN/A
Cap/Depr(3y)267.64%
Cap/Depr(5y)208.46%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-74.14%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-11.76%
EPS Next Y-30.59%
EPS Next 2Y-9.15%
EPS Next 3Y-0.45%
EPS Next 5YN/A
Revenue 1Y (TTM)95.17%
Revenue growth 3Y42.97%
Revenue growth 5YN/A
Sales Q2Q%72.71%
Revenue Next Year70.69%
Revenue Next 2Y46.99%
Revenue Next 3Y38.98%
Revenue Next 5Y31.98%
EBIT growth 1Y-164.8%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year33.48%
EBIT Next 3Y20.15%
EBIT Next 5Y20.65%
FCF growth 1Y-300.1%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-1765.16%
OCF growth 3YN/A
OCF growth 5YN/A
1LIFE HEALTHCARE INC / ONEM Fundamental Analysis FAQ
Can you provide the ChartMill fundamental rating for 1LIFE HEALTHCARE INC?
ChartMill assigns a fundamental rating of 3 / 10 to ONEM.
What is the valuation status of 1LIFE HEALTHCARE INC (ONEM) stock?
ChartMill assigns a valuation rating of 1 / 10 to 1LIFE HEALTHCARE INC (ONEM). This can be considered as Overvalued.
Can you provide the profitability details for 1LIFE HEALTHCARE INC?
1LIFE HEALTHCARE INC (ONEM) has a profitability rating of 0 / 10.
What is the earnings growth outlook for 1LIFE HEALTHCARE INC?
The Earnings per Share (EPS) of 1LIFE HEALTHCARE INC (ONEM) is expected to decline by -30.59% in the next year.